CRPOF Ceapro Inc.
Ceapro Inc., a biotechnology company, engages in developing and commercializing active ingredients in the United States, Canada, Germany, China, and internationally. The company is involved in the development and application of technology to the production of extracts and active ingredients from oats and other renewable plant resources. It adds value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company's products include natural active ingredients comprising beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; natural anti-aging skincare products; and veterinary therapeutic products, such as oat shampoos, ear cleansers, and dermal complexes/conditioners. Its products and technologies that are under research and development, or pre-commercial stage comprise a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; various novel enabling technologies, including Pressurized Gas eXpanded drying technology; and new oat variety and technologies to enhance the content of avenanthramides. The company was founded in 1997 and is headquartered in Edmonton, Canada.
Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol CV:CZO.
$0.38 OTCQX
As of 01/26/2022 OTCMarkets
Security Information
Category1: US Equity
Category2: Common stocks
Category3: Micro cap
GICS sector: Materials
Industry: Biotechnology
Index country: Canada
Country of incorporation:
IPO date: 10/19/2001
Outstanding shares: 7,768,543
Average volume: 12,311
Market cap: $3,022,740
Current dividend yield: 0.00%
Sedol:
Valuation (See tab for details)
PE ratio: 1.98
PB ratio: 1.14
PS ratio: 0.19
Return on equity: 5.78%
Net income %: 9.35%